Why the Central Laboratory is Becoming a Defining Advantage in Modern Clinical Trials
Download the white paper to learn more.
Clinical trials are more complex than ever, and the central laboratory sits at the heart of that complexity. This white paper examines the operational and scientific pressures facing today’s central labs and how the right partner can make the difference between a study that runs smoothly and one that does not.
Drawing on industry data and insights from Eurofins Central Laboratory Director of Scientific Affairs, the paper covers:
- Why rising trial complexity is reshaping what sponsors need from a central lab partner
- Why specimen integrity and global logistics require the same scientific rigor as the testing itself
- The challenge of harmonizing data across multiregional studies and what it takes to solve it
- How central laboratories are evolving from testing functions to strategic scientific partners
Whether you are planning a Phase 1 study or managing a global Phase 3 program, this paper offers a grounded perspective on what central laboratory excellence looks like in practice.